...
首页> 外文期刊>Journal of orthopaedic research >Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis.
【24h】

Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis.

机译:牵张成骨过程中局部应用血管内皮生长因子(VEGF)和VEGF抑制剂对兔胫骨的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

INTRODUCTION: Therapeutic angiogenesis, a novel concept in tissue engineering, is neo-formation of blood vessels in a tissue upon delivery of an angiogenic growth factor to the tissue. We hypothesised that therapeutic angiogenesis could enhance bone formation and challenged the hypothesis in an experimental model of distraction osteogenesis. METHODS: Rabbits, divided into three equal groups of 12, had their right tibia lengthened by distraction osteogenesis. A mini-osmotic pump delivered to the osteotomy gap either recombinant human vascular endothelial growth factor (VEGF), VEGF-inhibitor, or vehicle alone during the latency and distraction phase. After consolidation, we assessed bone blood flow by radioactive microsphere entrapment, measured torsional stiffness and bone mineral content, and did histomorphometry. RESULTS: VEGF and VEGF-inhibitor treatment failed to influence bone blood flow, torsional stiffness, bone mineral content and histomorphometric indices of the bone regenerate. However, VEGF treatment increased the blood flow in bone of the distracted limb and VEGF-inhibitor treatment decreased bone blood flow. CONCLUSION: The regenerate was unresponsive to VEGF and VEGF-inhibitor treatment in contrast to the neighbouring bone, which implies different biological properties of the vasculature in native and regenerating bone. VEGF is not recommended for enhancement of bone formation in this setting.
机译:引言:治疗性血管生成是组织工程学中的一个新概念,是在将血管生成生长因子传递到组织后组织中血管的新形成。我们假设治疗性血管生成可以增强骨形成,并在分散性成骨的实验模型中挑战了这一假设。方法:将兔子分成12组,每组三个相等,通过分散成骨作用延长其右胫骨长度。微型渗透泵在潜伏期和分心阶段将重组人血管内皮生长因子(VEGF),VEGF抑制剂或单独的媒介物输送至截骨间隙。巩固后,我们通过放射性微球截留评估骨血流量,测量扭转刚度和骨矿物质含量,并进行组织形态测定。结果:VEGF和VEGF抑制剂治疗未能影响骨血流量,扭转刚度,骨矿物质含量和骨再生的组织形态学指标。然而,VEGF治疗增加了分散注意力的肢体的骨中的血流,而VEGF抑制剂治疗降低了骨的血流。结论:与邻近骨相比,再生物对VEGF和VEGF抑制剂的治疗无反应,这暗示着天然和再生骨中脉管系统的生物学特性不同。在这种情况下,不建议使用VEGF来增强骨形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号